Make an Appointment

Edit Template

Multiple Myeloma

Home - Multiple Myeloma

What is Multiple Myeloma?

Multiple myeloma, often referred to simply as myeloma, is a rare but serious cancer that affects plasma cells in the bone marrow. In this comprehensive guide, we will delve into multiple myeloma, providing an overview, detailing its signs and symptoms, exploring its causes, types, and treatment options, and discussing the diagnostic process. By the end of this article, you will have a thorough understanding of this complex condition.

Multiple myeloma is a type of cancer that originates in plasma cells, a crucial component of the immune system responsible for producing antibodies. When myeloma develops, these plasma cells become cancerous, multiplying uncontrollably and crowding out healthy blood cells in the bone marrow.

Recognizing the signs and symptoms of multiple myeloma is essential for early diagnosis and effective treatment. Common indicators include:

1. Bone Pain
One of the hallmark symptoms of multiple myeloma is bone pain, which often occurs in the back, hips, and ribs. Fractures and bone damage can result from weakened bones.

2. Fatigue
Unexplained fatigue and weakness are common, as myeloma can lead to anemia, reducing the body's ability to transport oxygen.

3. Frequent Infections
Myeloma weakens the immune system, making individuals more susceptible to infections, which can become recurrent.

4. Kidney Problems
Myeloma can damage the kidneys, leading to symptoms like increased thirst, frequent urination, and swelling, particularly in the ankles and legs.

5. High Blood Calcium Levels
Elevated levels of calcium in the blood, known as hypercalcemia, can occur, causing symptoms like excessive thirst, frequent urination, and confusion.

6. Anemia
A decrease in healthy red blood cells can lead to anemia, resulting in fatigue, weakness, and pallor.

The exact cause of multiple myeloma remains uncertain, but several risk factors and associations have been identified:

1. Age
Myeloma is more common in older adults, with the majority of cases occurring after the age of 65.

2. Gender
Men are at a slightly higher risk of developing myeloma compared to women.

3. Race
African Americans are more likely to develop myeloma than individuals of other racial backgrounds.

4. Family History
Having a first-degree relative with myeloma may increase the risk of developing the disease.

5. Monoclonal Gammopathy of Undetermined Significance (MGUS)
MGUS is a precursor condition in which abnormal plasma cells are present but do not meet the criteria for myeloma. Individuals with MGUS have an increased risk of progressing to myeloma over time.

Multiple myeloma encompasses several subtypes, including:

1. IgG Myeloma
The most common subtype, characterized by abnormal IgG antibodies.

2. IgA Myeloma
This subtype involves abnormal IgA antibodies and accounts for a significant portion of myeloma cases.

3. Light Chain Myeloma
Also known as Bence Jones myeloma, it is characterized by the presence of abnormal light chain proteins in the urine.

Managing multiple myeloma involves a multidisciplinary approach and depends on the stage, subtype, and overall health of the patient. Common treatment options include:

1. Chemotherapy
Chemotherapy drugs are used to kill cancer cells and control the disease's progression.

2. Stem Cell Transplant
A stem cell transplant may be recommended for eligible patients to replace damaged bone marrow with healthy stem cells.

3. Targeted Therapy
Targeted therapy drugs focus on specific molecules involved in myeloma cell growth.

4. Immunomodulatory Drugs (IMiDs)
IMiDs, such as thalidomide and lenalidomide, boost the immune system's response to myeloma cells.

5. Monoclonal Antibodies
Monoclonal antibodies, like daratumumab and elotuzumab, target and destroy myeloma cells.

Diagnosing multiple myeloma involves several steps, including:

1. Blood and Urine Tests
Blood tests, such as a complete blood count (CBC) and serum protein electrophoresis, can identify abnormal protein levels. Urine tests may detect the presence of abnormal proteins.

2. Bone Marrow Aspiration and Biopsy
A bone marrow aspiration and biopsy are performed to collect samples from the bone marrow, allowing for the examination of plasma cells and confirmation of myeloma.

3. Imaging Studies
X-rays, CT scans, MRI scans, and PET scans are used to visualize bone damage and identify any tumors or abnormalities.

4. Other Tests
Additional tests, such as genetic testing and cytogenetic analysis, may be performed to assess the genetic characteristics of the myeloma cells.

Multiple myeloma is a complex and challenging condition that demands early detection and personalized treatment approaches. Understanding its signs, causes, types, treatment options, and diagnostic procedures is crucial for individuals affected by myeloma and those supporting them.

With advancements in medical care and research, individuals diagnosed with multiple myeloma have more treatment options and better prospects for improved quality of life.


Immune Thrombocytopenic Purpura (ITP)

Aplastic Anaemia

Aplastic Anemia





Bone Marrow Transplant

Bone Marrow Transplant

Best Hematology Services in Lucknow at RUDHIR AROGYA.

Quick Links

About Us





Useful Links

Privacy Policy

Terms and Conditions




Work Hours

Meet the best medical oncologist in Lucknow Dr SUNIL DABADGHAO

© 2023 Developed by E-Marketters